GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AbCellera Biologics Inc (STU:8QQ) » Definitions » Other Current Receivables

AbCellera Biologics (STU:8QQ) Other Current Receivables : €21.28 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is AbCellera Biologics Other Current Receivables?

AbCellera Biologics's Other Current Receivables for the quarter that ended in Mar. 2025 was €21.28 Mil.

AbCellera Biologics's quarterly Other Current Receivables declined from Sep. 2024 (€28.71 Mil) to Dec. 2024 (€25.34 Mil) but then stayed the same from Dec. 2024 (€25.34 Mil) to Mar. 2025 (€21.28 Mil).

AbCellera Biologics's annual Other Current Receivables declined from Dec. 2022 (€61.19 Mil) to Dec. 2023 (€30.99 Mil) and declined from Dec. 2023 (€30.99 Mil) to Dec. 2024 (€25.34 Mil).


AbCellera Biologics Other Current Receivables Historical Data

The historical data trend for AbCellera Biologics's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbCellera Biologics Other Current Receivables Chart

AbCellera Biologics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Receivables
Get a 7-Day Free Trial 0.40 12.64 61.19 30.99 25.34

AbCellera Biologics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.61 29.32 28.71 25.34 21.28

AbCellera Biologics Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


AbCellera Biologics Other Current Receivables Related Terms

Thank you for viewing the detailed overview of AbCellera Biologics's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


AbCellera Biologics Business Description

Traded in Other Exchanges
Address
150 W 4th Avenue, Vancouver, BC, CAN, V5Y 1G6
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

AbCellera Biologics Headlines

No Headlines